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Abstract 
Background: Cervical myelopathy and hydrocephalus occasionally occur in young children with achondroplasia.  
However, these conditions are not evaluated in a timely manner in many cases. The current study presents significant 
predictors for cervical myelopathy and hydrocephalus in young children with achondroplasia.
Methods: A retrospective analysis of 65 patients with achondroplasia who visited Seoul National University Children’s 
Hospital since 2012 was performed. The patients were divided into groups according to the presence of cervical 
myelopathy and hydrocephalus, and differences in foramen magnum parameters and ventricular parameters by mag‑
netic resonance imaging between groups were analyzed. Predictors for cervical myelopathy and hydrocephalus were 
analyzed, and the cut‑off points for significant ones were calculated.
Results: The group with cervical myelopathy showed foramen magnum parameters that indicated significantly 
lower cord thickness than in the group without cervical myelopathy, and the group with hydrocephalus showed sig‑
nificantly higher ventricular parameters and ‘Posterior indentation’ grade than the group without hydrocephalus. ‘Cord 
constriction ratio’ (OR 5199.90, p = 0.001) for cervical myelopathy and ‘Frontal horn width’ (OR 1.14, p = 0.001) and 
‘Posterior indentation’ grade (grade 1: OR 9.25, p = 0.06; grade 2: OR 18.50, p = 0.01) for hydrocephalus were significant 
predictors. The cut‑off points for cervical myelopathy were ‘Cord constriction ratio’ of 0.25 and ‘FM AP’ of 8 mm (AUC 
0.821 and 0.862, respectively) and ‘Frontal horn width’ of 50 mm and ‘Posterior indentation’ grade of 0 (AUC 0.788 and 
0.758, respectively) for hydrocephalus.
Conclusion: ‘Cord constriction ratio’ for cervical myelopathy and ‘Frontal horn width’ and ‘Posterior indentation’ grade 
for hydrocephalus were significant predictors and may be used as useful parameters for management. ‘Posterior 
indentation’ grade may also be used to determine the treatment method for hydrocephalus.
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Background
Achondroplasia is the most common form of dwarfism, 
occurring in 1 in 26,000 live-born infants [1]. High cer-
vical myelopathy occasionally occurs in young children 
with achondroplasia [2, 3]. Although the risk of unex-
pected death due to craniocervical constriction decreases 
after the first year [1, 4, 5], the small size of the foramen 
magnum does not change, which may increase the like-
lihood of insidious or accidental cord injury. T2 high 
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signal intensity (HSI) in the cervical cord is observed on 
magnetic resonance imaging (MRI) in 40% of asympto-
matic achondroplasia patients [6–8].
Approximately 4.3% of achondroplasia patients require 
ventriculo-peritoneal (VP) shunts [9]. Ventriculomegaly 
may be observed in asymptomatic patients [10]. Symp-
toms of acute hydrocephalus rarely occur, but tense 
fontanel, prominence of superficial venous patterning, 
lethargy, and irritability do appear insidiously. Unlike 
other hydrocephalus patients, the size of the cranial 
base, which is formed by endochondral ossification, is 
smaller, and the jugular foramen is also smaller. This con-
dition causes a partial obstruction of venous flow, which 
increases intracranial venous pressure and causes prob-
lems with the venous resorption of cerebrospinal fluid 
(CSF) [11–13]. CSF flow obliteration at the craniocervi-
cal junction has also been suggested as a factor in some 
studies [14], and a VP shunt is considered the standard 
treatment.
Cervical myelopathy and hydrocephalus may occur 
in young children with achondroplasia. However, these 
conditions are not evaluated in a timely manner, and 
the outcomes lead to permanent neurological deficits in 
patients. Therefore, we identified significant predictors 




Since 1985, 125 patients with achondroplasia vis-
ited Seoul National University Children’s Hospital. A 
total of 108 patients visited since 2012, with well-doc-
umented patient records. We excluded older patients 
(> 30  months) because most of them were outside the 
vulnerable period for cervical myelopathy or had already 
received surgical procedures at other institutions. Eighty-
seven patients were under 30-months-old at the first 
visit. We included 79 patients who were followed for 
more than 6 months. Three patients for whom MRI was 
not performed were excluded. To apply consistent evalu-
ation criteria, 65 patients who were continuously man-
aged by a single pediatrician and a single neurosurgeon 
were ultimately included (Fig.  1). All 65 patients were 
clinically diagnosed with a de novo case of achondro-
plasia without family history and confirmed to have the 
FGFR3 NP_000133.1:p.(Gly380Arg) mutation. The iden-
tification of a heterozygous pathogenic variant in FGFR3 
using molecular genetic testing establishes the diagnos-
tic confirmation of achondroplasia. Because a common 
pathogenic variant, p.Gly380Arg, is identified in approxi-
mately 98% of patients with achondroplasia, we first 
performed targeted Sanger analysis [15, 16] of the ‘muta-
tion-hot spot’ p.Gly380Arg and detected this common 
mutation in all patients who participated in the study. 
DNA was extracted from peripheral blood leukocytes 
from each patient and amplified using PCR and a primer 
pair of FGFR3 exon 8. Direct Sanger sequencing was sub-
sequently performed using amplified PCR products and 
revealed a common pathogenic mutation, p.Gly380Arg, 
in all participants.
Criteria for the diagnosis and treatment of cervical 
myelopathy and hydrocephalus
MRI for spinal cord injury was considered for all patients 
at 6  months of age, but this screening was infrequently 
used because many of the patients were well over 
6  months of age when they visited our institution. The 
treatment plan was established based on the symptoms 
of the patients and the MRI findings at the first visit and 
follow-up.
Cervical myelopathy was diagnosed when there were 
(1) neurological abnormalities, including long tract sign, 
apnea, or a history of respiratory arrest or (2) evidence 
of spinal cord injury (HSI on T2 images of MRI). We per-
formed foramen magnum decompression (FMD) when 
patients had (1), (2), or (3) severe indentation (50% or 
greater than normal cord thickness) of the cervical spi-
nal cord on the initial MRI. Except for the two initial 
patients, C1 laminectomy was also performed with FMD. 
Intraoperative neurophysiological monitoring was per-
formed in all patients to prevent spinal cord injury, and 
decompression was performed sufficiently larger than the 
cord width as measured on preoperative MRI.
Hydrocephalus was diagnosed when there were (1) 
overt neurological abnormalities, such as irritability, eye-
ball movement limitation, or sunset sign, (2) abnormali-
ties on physical examination, such as rapid increases in 
head circumference (HC), tense fontanel, or scalp vein 
engorgement, accompanied by (3) overt ventriculomeg-
aly with periventricular T2 HSI on MRI. A VP shunt was 
indicated when symptoms and signs were severe, such as 
rapidly increasing ventricular size; FMD was performed 
when the symptoms and signs were not severe, and the 
risk of cervical myelopathy was likely to be high, consid-
ering the long-term complications of VP shunts. These 
decisions were based on clinical assessments but were 
not determined using objective parameters.
Parameters for predicting cervical myelopathy 
and hydrocephalus
Using the T2 sagittal image of MRI, the anterior–poste-
rior diameter of the foramen magnum (FM AP), exclud-
ing the soft tissue portion, of the symptomatic group and 
the asymptomatic group was measured, and the cord 
signal change was checked (Fig.  2). Using the T1 sagit-
tal image of MRI, the cord thickness at the level of the 
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foramen magnum (Cord thickness FM), the narrowest 
cord thickness between the foramen magnum and C2 
(Cord thickness narrowest), and the cord thickness at the 
level of C2 (Cord thickness C2) were measured.
We created four new parameters: ‘Cord constric-
tion ratio’, ‘Anterior indentation’, ‘Posterior indenta-
tion’, and ‘Indentation index’. The ‘Cord constriction 
ratio’ was the value obtained by ‘1—(‘Cord thickness 
narrowest’/‘Cord thickness C2’ which is the normal 
part)’. Cord indentation was graded from the anterior 
and posterior sides after the cord was divided into 4 
parts in the longitudinal direction based on ‘Cord 
thickness C2’ (grade 0: no indentation; grade 1: below 
25%; grade 2: 25% or above) (Fig. 3). The ‘Indentation 
index’ was obtained by adding the grades of the ‘Ante-
rior indentation’ and ‘Posterior indentation’. ‘Fron-
tal horn width’, ‘Evans ratio’, and ‘Periventricular HSI’ 
 (mm2) were also measured using T2 axial images.
Fig. 1 Flowchart of the patients
Page 4 of 10Shim et al. Orphanet J Rare Dis           (2021) 16:81 
Statistical analysis
We retrospectively compared differences in the fora-
men magnum (FM) parameters (‘FM AP’, ‘Cord con-
striction ratio’, ‘Anterior indentation’, ‘Posterior 
indentation’, and ‘Indentation index’) and ventricu-
lar parameters (‘Frontal horn width’, ‘Evans ratio’, and 
‘Periventricular HSI’) according to the presence of cer-
vical myelopathy and hydrocephalus using independent 
T-tests and Fisher’s exact test.
Logistic regression analyses for cervical myelopathy 
and hydrocephalus were performed using the parameters 
described above to identify significant predictors. Uni-
variate analyses using each parameter were performed for 
cervical myelopathy and hydrocephalus. Because many 
parameters were highly interrelated (e.g., when ‘FM AP’ 
was lower, ‘Cord constriction ratio’ was higher in most 
instances), we selected relatively more significant param-
eters from FM parameters and ventricular parameters. 
Fig. 2 ‘FM AP’ (A) was measured using T2 sagittal MRI images. The T1 sagittal MRI image was used to measure ‘Cord thickness narrowest’ (B) and 
‘Cord thickness C2’ (C). We created a new parameter called ‘Cord constriction ratio’ and calculated it as ‘1—(B/C)’
Fig. 3 After the cord was divided longitudinally into 4 sections based on ‘Cord thickness C2’, cord indentation was graded (grade 1: < 25%, A; 
grade 2: ≥ 25%, B) at the anterior and posterior parts. The ‘Indentation index’ was calculated by adding the grades of the ‘Anterior indentation’ and 
‘Posterior indentation’
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Basic parameters (age, sex) were added to create a gener-
alized linear model. Multivariate analysis was performed 
with the constructed model without multicollinearity.
A receiver operating characteristic (ROC) curve was 
drawn using the significant predictors to calculate the 
most appropriate cut-off point. Significant findings were 
based on a P value of 0.05 or less. All statistical analyses 
were performed using R version 4.0.0. The Institutional 
Review Boards of our institution approved this study, and 
patient consent was not required.
Results
Patients’ characteristics
Thirteen (20%) of the 65 patients showed T2 HSI on 
MRI, long tract sign, or respiratory difficulty that cor-
responded to cervical myelopathy, and 8 patients (12%) 
had symptoms or signs related to hydrocephalus, such as 
scalp vein engorgement, tense fontanel, and papilledema. 
Four (6%) patients had symptoms of cervical myelopathy 
and hydrocephalus. Twenty-one patients (32%) under-
went FMD, and 1 patient (2%) had a VP shunt. Six of 
the patients who underwent FMD (9%) had no symp-
toms or signs of cervical myelopathy or hydrocephalus 
but did have severe cord indentation, a low ‘FM AP’, and 
a high ‘Cord constriction ratio’, which led to preventive 
surgery. The mean follow-up period for all patients was 
44 months, and it was 33 months for patients who under-
went surgery.
Differences in FM parameters and ventricular parameters 
according to patient status
Comparison of the patient characteristics and measure-
ments according to the presence of cervical myelopa-
thy or hydrocephalus (Tables 1 and 2) revealed that the 
patients with cervical myelopathy showed a significantly 
lower ‘FM AP’ (p < 0.001) and higher ‘Cord constriction 
ratio’, ‘Anterior indentation’, ‘Posterior indentation’ grade, 
and ‘Indentation index’ than patients without cervical 
myelopathy (all p < 0.001). Notably, there was no cervical 
myelopathy in the absence of indentation.
Nine patients had no cervical myelopathy, but FMD 
was performed. They had grade 1 or 2 ‘Posterior indenta-
tion’ with a narrow cord thickness (‘Cord thickness nar-
rowest’: 3.31–5.33  mm). In contrast, 1 patient did not 
undergo FMD despite cord injury. T2 HSI was observed 
in the cervical spinal cord on MRI, but the patient had no 
symptoms, and the FM parameters were not bad overall 
(‘FM AP’: 9.10 mm; ‘Cord thickness narrowest’: 5.74 mm; 
‘Cord constriction ratio’: 0.07; ‘Anterior indentation’: 
grade 1; and ‘Posterior indentation’: grade 1). The patient 
was already 25 months old at the time of the outpatient 
visit and was thought to have had a spinal cord injury 
when she was younger. The patient had been doing well 
without any problems as the foramen magnum widened.
The patients with hydrocephalus had a significantly 
higher ‘Frontal horn width’ and ‘Evans ratio’ (both 
p = 0.002) than patients without hydrocephalus. None 
of the FM parameters, except ‘Posterior indentation’, 
showed significant differences, but ‘Posterior indentation’ 
Table 1 Differences in  patient characteristics 
and  measurements according to  the  presence of  cervical 
myelopathy
FM Foramen magnum, AP anterior–posterior diameter, BPD bi-parietal diameter, 
HSI high signal intensity, FMD foramen magnum decompression, VP ventriculo-
peritoneal
a Data are presented as n (%) or mean ± SD
Characteristics 
and  parametersa
Yes No p value
N 13 52
Sex
 Male 8 (62) 28 (54) 0.85
 Female 5 (38) 24 (46)
Age (months) 11.7 ± 6.1 14.6 ± 9.3 0.29
Follow up period (months) 31.0 ± 22.3 41.8 ± 23.8 0.15
FM AP (mm) 6.06 ± 1.66 9.10 ± 2.22  < 0.001
Cord constriction ratio 0.37 ± 0.19 0.16 ± 0.12  < 0.001
Anterior indentation
 0 0 (0) 24 (46)  < 0.001
 1 3 (23) 21 (40)
 2 10 (77) 7 (14)
Posterior indentation
 0 0 (0) 38 (73)  < 0.001
 1 7 (54) 8 (15)
 2 6 (46) 6 (12)
Indentation index
 0 0 (0) 22 (42)  < 0.001
 1 0 (0) 15 (29)
 2 3 (23) 8 (15)
 3 4 (31) 4 (8)
 4 6 (46) 3 (6)
Frontal horn width (mm) 43.94 ± 11.04 40.61 ± 7.88 0.22
BPD (mm) 141.17 ± 7.46 136.40 ± 8.34 0.06
Evans ratio 0.31 ± 0.07 0.30 ± 0.06 0.51
Periventricular HSI 22.09 ± 20.33 11.46 ± 11.92 0.02
FMD
 Yes 12 (92) 9 (17)
 No 1 (8) 43 (83)
VP shunt
 Yes 0 (0) 1 (2)
 No 13 (100) 51 (98)
Later event
 Yes 0 (0) 2 (4) 1.00
 No 13 (100) 50(96)
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was significantly different (p = 0.009). In the absence of 
‘Posterior indentation’, the probability of having hydro-
cephalus was only 3% (1 of 38). However, the probabil-
ity with grade 1 ‘Posterior indentation’ was 20% (3 of 15), 
and the probability with grade 2 was 33% (4 of 12).
Except for two patients, all (97%) who underwent 
surgery or observed according to our criteria did well 
without any events. Later events, such as any neurologi-
cal symptoms or signs that occurred during follow-up, 
only occurred in 2 patients who were followed without 
surgery. One of these two patients tended to have better 
values than the other patients with cervical myelopathy 
(‘FM AP’: 8.52 mm; ‘Cord thickness narrowest’: 5.75 mm; 
‘Cord constriction ratio’: 0.03; ‘Anterior indentation’: 
grade 1; and ‘Posterior indentation’: grade 0), but tem-
porary respiratory difficulty did occur after the patient 
slipped and fell during follow-up. At the time of the out-
patient visit, she had already recovered and did not need 
further treatment. The other patient also had better val-
ues than the other patients with cervical myelopathy (‘FM 
AP’: 10.01  mm; ‘Cord thickness narrowest’: 5.08  mm; 
‘Cord constriction ratio’: 0.19; ‘Anterior indentation’: 
grade 0; and ‘Posterior indentation’: grade 0), but ven-
triculomegaly was present without obvious symptoms of 
hydrocephalus. During follow-up, he presented delayed 
speech development and an increased ventricular size, 
which led to surgery.
Identification of predictors for cervical myelopathy 
and hydrocephalus
Predictors for cervical myelopathy
Based on the univariate analyses for the identifica-
tion of predictors for cervical myelopathy, ‘FM AP’ and 
‘Cord constriction ratio’ were significant (all p = 0.001), 
and the odds ratios (ORs) of these parameters tended to 
increase as ‘FM AP’ decreased or ‘Cord constriction ratio’ 
increased (Table  3). Basic parameters (sex, age), ‘Cord 
constriction ratio’, which was the most significant of the 
FM parameters, and ‘Frontal horn width’, which was the 
most significant of the ventricular parameters in univari-
ate analyses, were used to create the generalized linear 
model for cervical myelopathy. Indentation parameters 
(‘Anterior indentation’, ‘Posterior indentation’, and ‘Inden-
tation index’) were not included in the model because 
these factors were not significant in univariate analysis 
and showed multicollinearity with ‘Cord constriction 
ratio’. Multivariate logistic regression using the model 
revealed ‘Cord constriction ratio’ as an important predic-
tor for cervical myelopathy, which was similar to the uni-
variate analysis (OR 4059.18, p = 0.002).
Predictors for hydrocephalus
Based on univariate analyses for the identification of pre-
dictors for hydrocephalus, ‘Frontal horn width’ and ‘Evans 
ratio’ were significant (p = 0.001 and 0.01, respectively), 
as expected, and ‘Posterior indentation’ among the FM 
parameters was surprisingly statistically significant (grade 
1: OR 9.25, p = 0.06; grade 2: OR 18.50, p = 0.01) (Table 4). 
Multivariate logistic regression analysis was performed 
with basic parameters (sex, age), ‘Frontal horn width’, and 
Table 2 Differences in  patient characteristics 
and  measurements according to  the  presence 
of hydrocephalus
FM Foramen magnum, AP anterior–posterior diameter, BPD bi-parietal diameter, 
HSI high signal intensity, FMD foramen magnum decompression, VP ventriculo-
peritoneal






 Male 5 (63) 31 (54) 0.96
 Female 3 (37) 26 (46)
Age (months) 7.25 ± 4.20 14.98 ± 8.92 0.02
Follow up period (months) 18.12 ± 17.90 42.63 ± 22.99 0.005
FM AP (mm) 6.78 ± 1.90 8.73 ± 2.42 0.03
Cord constriction ratio 0.28 ± 0.14 0.19 ± 0.16 0.145
Anterior indentation
 0 3 (38) 21 (37) 0.20
 1 1 (12) 23 (40)
 2 4 (50) 13 (23)
Posterior indentation
 0 1 (12) 37 (65) 0.009
 1 3 (38) 12  (21)
 2 4 (50) 8 (14)
Indentation index
 0 1 (12) 21 (37) 0.19
 1 1 (12) 14 (25)
 2 2 (25) 9 (16)
 3 1 (12) 7 (12)
 4 3 (38) 6 (10)
Frontal horn width (mm) 49.85 ± 11.70 40.08 ± 7.46 0.002
BPD (mm) 138.96 ± 13.40 137.13 ± 7.53 0.57
Evans ratio 0.36 ± 0.08 0.29 ± 0.05 0.002
Periventricular HSI  (mm2) 22.49 ± 22.98 12.34 ± 12.65 0.06
FMD
 Yes 7 (88) 14 (25)
 No 1 (12) 43 (75)
VP shunt
 Yes 1 (12) 0 (0)
 No 7 (88) 57 (100)
Later event
 Yes 0 (0) 2 (3) 1.00
 No 8 (100) 55 (97)
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‘Posterior indentation’, and ‘Frontal horn width’ showed 
statistical significance (OR 1.16, p = 0.05), and ‘Poste-
rior indentation’ also showed a certain trend toward sig-
nificance (grade 1: OR 19.72, p = 0.08; grade 2: OR 14.88, 
p = 0.08), which was similar to univariate analyses.
Identification of the most appropriate cut-off points 
of predictors using the ROC curves
Cervical myelopathy (Table 5, Fig. 4)
The most appropriate cut-off points for ‘FM AP’ and 
‘Cord constriction ratio’ were 8.02  mm and 0.25, 
respectively. ‘FM AP’ and ‘Cord constriction ratio’ 
showed high AUCs (0.862 and 0.821, respectively). ‘FM 
AP’ was relatively sensitive (92.3%), and ‘Cord con-
striction ratio’ was relatively specific (80.8%). Nota-
bly, none of the patients with an ‘FM AP’ of 8 mm or 
greater needed FMD. When the specificity was greater 
than 95%, the highest ‘FM AP’ was 5.5 mm (Specificity 
96%, Sensitivity 46%) and the lowest ‘Cord constriction 
ratio’ was 0.40 (Specificity 96%, Sensitivity 31%).
Table 3 Univariate and multivariate logistic regression analysis of parameters for cervical myelopathy
OR Odds ratio, CI confidence interval, FM foramen magnum, AP anterior–posterior diameter, Inf Infinite
Parameter Univariate analysis Multivariate analysis
OR 95% CI p value OR 95% CI p value
Sex: female 0.73 0.21–2.53 0.62 1.01 0.21–4.79 0.99
Age 0.95 0.86–1.05 0.29 0.98 0.88–1.10 0.77
FM AP 0.46 0.29–0.73 0.001
Cord constriction ratio 5199.90 31.64–854,573.57 0.001 4059.18 23.04–715,067.58 0.002
Anterior indentation grade 1 0.00‑Inf 0.99
Anterior indentation grade 2 0.00‑Inf 0.99
Posterior indentation grade 1 0.00‑Inf 0.99
Posterior indentation grade 2 0.00‑Inf 0.99
Indentation index 1 0.00‑Inf 1.00
Indentation index 2 0.00‑Inf 1.00
Indentation index 3 0.00‑Inf 1.00
Indentation index 4 0.00‑Inf 1.00
Frontal horn width 1.04 0.97–1.12 0.22 1.01 0.93–1.11 0.77
Evans ratio 32.25 0.00–808,255.26 0.50
Table 4 Univariate and multivariate logistic regression analysis of parameters for hydrocephalus
OR Odds ratio, CI confidence interval, FM foramen magnum, AP anterior–posterior diameter, Inf infinite
Parameter Univariate analysis Multivariate analysis
OR 95% CI p value OR 95% CI p value
Sex: female 0.72 0.16–3.28 0.67 4.65 0.27–78.89 0.29
Age 0.67 0.50–0.90 0.008 0.74 0.54–1.00 0.05
FM AP 0.69 0.48–0.99 0.05
Cord constriction ratio 0.05 0.00–3.15 0.15
Anterior indentation grade 1 0.30 0.03–3.16 0.32
Anterior indentation grade 2 2.15 0.41–11.20 0.36
Posterior indentation grade 1 9.25 0.88–97.47 0.06 19.72 0.72–543.40 0.08
Posterior indentation grade 2 18.50 1.82–188.39 0.01 14.88 0.73–303.86 0.08
Indentation index 1 1.50 0.09–36.01 0.78
Indentation index 2 4.67 0.37–58.24 0.23
Indentation index 3 3.00 0.16–54.56 0.45
Indentation index 4 10.05 0.92–120.24 0.06
Frontal horn width 1.14 1.03–1.26 0.001 1.16 1.00–1.35 0.05
Evans ratio 159,603,019 63.5‑Inf 0.01
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Hydrocephalus (Table 5, Fig. 5)
The most appropriate cut-off points for ‘Posterior 
indentation’ and ‘Frontal horn width’ were grade 0 and 
50.63 mm, respectively. ‘Posterior indentation’ and ‘Fron-
tal horn width’ showed high AUCs (0.788 and 0.758, 
respectively). ‘Posterior indentation’ was relatively sensi-
tive (87.5%), and ‘Frontal horn width’ was relatively spe-
cific (91.2%). ‘Frontal horn width’ showed the expected 
results, but it was surprising that ‘Posterior indentation’ 
was a good predictor for hydrocephalus.
The practical guideline for FMD based on our study
Based on the above analyses, we established a practical 
guideline for FMD: (1) symptoms or signs of cervical 
myelopathy; (2) evidence of cervical spinal cord injury 
(T2 HSI on MRI); (3) significant cervical spinal cord 
compression (absolute indication: ‘FM AP’ ≤ 5.5  mm or 
‘Cord constriction ratio’ ≥ 0.40; relative indication: ‘FM 
AP’ ≤ 8.0  mm or ‘Cord constriction ratio’ ≥ 0.25); and 
(4) ‘Posterior indentation’ in chronic hydrocephalus with 
mild symptoms, in which VP shunt should be considered 
when symptoms are acute and severe.
Discussion
Twenty-two of the 65 patients (34%) in our study under-
went surgery, which is a rate somewhat higher than in 
other papers (9.4–11.7%) [5, 9]. This difference may be 
the result of the referral of relatively severe cases to our 
institution. Considering the rates of later events in the 
patients who underwent surgery (0%, 0 of 22) and who 
were observed (5%, 2 of 43), the surgical indication was 
properly applied to the patients, but it may suggest that 
the surgical indications should be broadened.
The use of parameters as predictors for cervical 
myelopathy
Our achondroplasia patients underwent their first MRI at 
14.0 months on average. If only those with cervical mye-
lopathy were analyzed, the patients underwent their first 
MRI at 11.7 months on average. If cord injury had already 
occurred, neurological deficits remained even after FMD. 
Table 5 The cut-off points calculated using ROC curves and its sensitivity, specificity and AUC 
ROC Receiver operating characteristics, AUC area under the ROC curve, FM foramen magnum, AP anterior–posterior diameter
Predictor Cut-off point Sensitivity (%) Specificity (%) AUC 
Cervical myelopathy
FM AP 8.02 mm 92.3 69.2 0.862
Cord constriction ratio 0.25 76.9 80.8 0.821
Hydrocephalus
Posterior indentation Grade 0 87.5 64.9 0.788
Frontal horn width 50.63 mm 75.0 91.2 0.758
Fig. 4 ROC curve for predicting cervical myelopathy using ‘FM AP’ (a) 
and ‘Cord constriction ratio’ (b)
Fig. 5 ROC curve for predicting hydrocephalus using ‘Posterior 
indentation’ (a) and ‘Frontal horn width’ (b)
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Therefore, we needed an appropriate MRI screening for 
achondroplasia patients and significant predictors that 
may be used to observe progression or determine pre-
ventive surgery. However, there was no clear consensus 
on this issue [17].
We suggest the following guidelines based on the 
results of our research. First, we recommend perform-
ing the first MRI no later than 4  months after birth in 
patients with achondroplasia. This timing is because the 
youngest of our patients who showed T2 HSI on MRI was 
5 months old. MRI has been recommended at 1 month of 
age recently [18]. After the initial MRI, it would be good 
to perform follow-up MRIs at appropriate intervals (e.g., 
8 and 12 months of age). Second, we propose the meas-
urement of ‘FM AP’, ‘Cord constriction ratio’, and ‘Poste-
rior indentation’ grade based on the MRIs performed at 
each follow-up, and the evaluation of any deviation from 
the cut-off point in these various predictors (for cervical 
myelopathy: when ‘FM AP’ is < 8 mm or ‘Cord constric-
tion ratio’ > 0.25; for hydrocephalus: when ‘Frontal horn 
width’ > 50  mm or ‘Posterior indentation’ is observed). 
When these conditions appear, we can consider exam-
ining the symptoms and signs of cervical myelopathy 
and hydrocephalus more closely, and we can use these 
parameters to predict the group of patients who are likely 
to have problems in the future and consider performing 
preventive surgery before symptoms or signs occur.
The use of parameters for determining the treatment 
method of hydrocephalus
Unlike cervical myelopathy, hydrocephalus tends to pro-
gress insidiously rather than acutely, and develop revers-
ible neurological deficits [9, 10, 19–21]. Considering 
the complications of VP shunts [22], it is appropriate to 
observe the progression sufficiently and consider surgery 
when clear symptoms develop.
‘Posterior indentation’, ‘Frontal horn width’ and ‘Evans 
ratio’ were considered predictors of hydrocephalus. Con-
sidering these factors and the anatomical location, ‘Pos-
terior indentation’ of the cord at the level of the foramen 
magnum may be considered a sign of craniocervical CSF 
flow obstruction. Other studies described that venous 
hypertension due to jugular foramen narrowing contrib-
uted to the development of hydrocephalus, and the role 
of CSF flow obstruction by foramen magnum stenosis is 
relatively small [12, 23, 24]. However, all of these publi-
cations were case reports or case series, and clear evi-
dence is lacking. Our findings suggest that FMD, instead 
of VP shunt, may resolve hydrocephalus in symptomatic 
patients with ventriculomegaly who have evident ‘Poste-
rior indentation’. Cine MRI is sometimes used [25], but 
clear evidence is lacking, and this method has the disad-
vantage of requiring an additional MRI.
Eight of our patients presented with symptoms or signs 
of chronic hydrocephalus. Four of them had T2 HSI and 
‘Posterior indentation’ (grades 1, 1, 2, and 2), and 3 of 
them had only ‘Posterior indentation’ (grades 1, 2, and 
2) in the cord on MRI. Therefore, FMD was performed 
first. The other patient showed severe ventriculomegaly 
(‘Frontal horn width’: 67.85  mm; ‘Evans ratio’: 0.513) 
without any abnormalities in the cord on MRI, and VP 
shunt was performed. As expected, the outcomes of the 
7 patients who underwent FMD were good. The signs of 
hydrocephalus, such as scalp vein engorgement, tense 
fontanel, and papilledema, resolved in all patients with-
out additional VP shunt. In one patient, ‘Evans ratio’ 
decreased from 0.37 to 0.34 after 7 months, and the HC 
decreased from the 95th percentile to the 75th percen-
tile 32 months after surgery. Similar cases were found in 
other studies [10, 26].
Our study has some limitations. First, due to the large 
variation in the time of the patients’ first visits, the time 
when MRI was performed varied from 5 to 49  months. 
Second, this study was a retrospective analysis performed 
with patient outcomes to identify predictors. However, 
consistency was maintained to some extent in that it was 
the result of management based on prospective criteria. 
Third, the number of patients with hydrocephalus was 
small. Therefore, the analysis requires more patients.
Conclusion
‘FM AP’ and ‘Cord constriction ratio’ may be used to 
predict cervical myelopathy, and the most significant 
predictor was ‘Cord constriction ratio’. Measurement of 
these factors according to the screening program allows 
closer patient observation and consideration of preven-
tive surgery in patients with predictors that deviate from 
the cut-off points. ‘Posterior indentation’, ‘Frontal horn 
width’ and ‘Evans ratio’ may be used in the prediction of 
hydrocephalus, and FMD should be considered first in 
patients with severe ‘Posterior indentation’ with satisfac-
tory results to avoid VP shunt.
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